Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling
- DOI
- 10.3390/ijms27156666
- Published
- 2026-07-26
- Container
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27156666,
title = {Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling},
author = {Eman H. Yousef and Samia S. Hawas and Mohamed M. Salama and Mostafa E. Metawee and Hader I. Sakr and Sumaiah J. Alarfaj and Amany A. Alzokaky},
year = {2026},
journal = {International Journal of Molecular Sciences},
doi = {10.3390/ijms27156666},
url = {https://doi.org/10.3390/ijms27156666}
}RIS
TY - JOUR TI - Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling AU - Eman H. Yousef AU - Samia S. Hawas AU - Mohamed M. Salama AU - Mostafa E. Metawee AU - Hader I. Sakr AU - Sumaiah J. Alarfaj AU - Amany A. Alzokaky PY - 2026 JO - International Journal of Molecular Sciences DO - 10.3390/ijms27156666 UR - https://doi.org/10.3390/ijms27156666 ER -
APA
Yousef, E. H., Hawas, S. S., Salama, M. M., Metawee, M. E., Sakr, H. I., Alarfaj, S. J., & Alzokaky, A. A. (2026). Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27156666
Source records
- crossref · retrieved 2026-11-10T11:11:32.527Z